OSCR Oscar Health, Inc.
Hospital & Medical Service Plans · NYSE · SEC CIK 1568651 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY54.8%
TTM net income YoY450.5%
TTM EPS YoY350.0%
Revenue 3-yr CAGR47.7%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin5.4%
Net margin4.9%
FCF margin23.7%
EBITDA margin5.5%
Returns
ROE52.7%
ROA10.9%
ROIC (approx.)—
Asset turnover2.22x
Leverage & solvency
Liabilities / assets77.8%
Debt / equity0.19x
Current ratio1.14x
Interest coverage68.29x
Cash quality & payout
Operating cash flow / net income4.89x
Accruals ratio-42.2%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B |
| SG&A expense | $2.05B | $1.76B | $1.43B | $1.26B | $265.08M |
| Operating income | -$396.36M | $57.27M | -$235.62M | -$589.87M | -$544.48M |
| Interest expense | $17.60M | $23.73M | $24.60M | $22.62M | $4.72M |
| Pretax income | -$437.30M | $33.43M | -$267.30M | -$610.08M | -$570.58M |
| Income tax | $5.61M | $7.30M | $3.29M | -$523,000 | $846,000 |
| Net income | -$443.15M | $25.43M | -$270.73M | -$606.27M | -$572.61M |
| EBITDA | -$367.46M | $89.41M | -$204.92M | -$574.58M | -$529.88M |
| EPS (basic) | -1.69 | 0.11 | -1.22 | -2.85 | -3.20 |
| EPS (diluted) | -1.69 | 0.10 | -1.22 | -2.85 | -3.20 |
| Weighted avg. shares (diluted) | 262.39M | 265.85M | 221.66M | 212.47M | 178.97M |
| Balance sheet | |||||
| Cash & equivalents | $2.77B | $1.55B | $1.87B | $1.58B | $1.13B |
| Short-term investments | $1.22B | $624.46M | $689.83M | $1.40B | $587.09M |
| Receivables | $362.68M | — | — | — | — |
| Current assets | $4.61B | $2.85B | $3.06B | $4.12B | $2.31B |
| PP&E, net | $88.35M | $66.79M | $61.93M | $59.89M | $46.61M |
| Total assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B |
| Current liabilities | $4.86B | $3.46B | $2.43B | $3.26B | $1.85B |
| Long-term debt | $430.10M | $299.56M | $298.78M | $298.00M | $0 |
| Total debt | $430.10M | $299.56M | $298.78M | $298.00M | $0 |
| Total liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B |
| Shareholders' equity | $977.65M | $1.01B | $803.97M | $890.38M | $1.39B |
| Net debt | -$2.34B | -$1.25B | -$1.57B | -$1.28B | -$1.13B |
| Cash flow statement | |||||
| Operating cash flow | $1.09B | $978.19M | -$272.16M | $380.35M | -$181.75M |
| Capital expenditure | $36.37M | $27.90M | $25.58M | $29.01M | $25.89M |
| Free cash flow | $1.06B | $950.30M | -$297.74M | $351.34M | -$207.63M |
| Investing cash flow | -$241.06M | -$1.39B | $577.19M | -$226.52M | -$774.51M |
| Financing cash flow | $399.21M | $68.39M | $6.45M | $301.11M | $1.24B |
| Depreciation & amortization | $28.89M | $32.15M | $30.69M | $15.28M | $14.61M |
| Stock-based compensation | $87.65M | $109.82M | $159.68M | $112.33M | $86.30M |
| Share buybacks | — | — | — | — | $0 |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.